AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications. Amacathera has just closed its seed financing round with US$3.6M and is looking to begin Phase I clinical trials in the near future. For more information visit amacathera.ca
No upcoming sessions. Check back soon.